Tulsa Wealth Advisors INC Acquires Shares of 20,596 CME Group Inc. $CME

Tulsa Wealth Advisors INC acquired a new stake in CME Group Inc. (NASDAQ:CME) during the 2nd quarter, according to its most recent filing with the SEC. The institutional investor acquired 20,596 shares of the financial services provider’s stock, valued at approximately $4,548,000.

Other hedge funds have also modified their holdings of the company. Asset Dedication LLC grew its position in CME Group by 64.9% in the fourth quarter. Asset Dedication LLC now owns 94 shares of the financial services provider’s stock valued at $26,000 after acquiring an additional 37 shares during the period. Whipplewood Advisors LLC raised its stake in CME Group by 2,075.0% during the first quarter. Whipplewood Advisors LLC now owns 87 shares of the financial services provider’s stock worth $26,000 after acquiring an additional 83 shares in the last quarter. Elkhorn Partners Limited Partnership bought a new position in shares of CME Group during the fourth quarter valued at $27,000. Hilton Head Capital Partners LLC bought a new position in shares of CME Group during the fourth quarter valued at $28,000. Finally, Legacy Wealth Managment LLC ID boosted its stake in shares of CME Group by 191.9% in the 4th quarter. Legacy Wealth Managment LLC ID now owns 108 shares of the financial services provider’s stock valued at $29,000 after purchasing an additional 71 shares in the last quarter. 87.75% of the stock is owned by institutional investors and hedge funds.

Insider Activity at CME Group

In related news, Director William R. Shepard purchased 325 shares of the firm’s stock in a transaction dated Thursday, June 25th. The shares were acquired at an average cost of $230.57 per share, with a total value of $74,935.25. Following the completion of the purchase, the director directly owned 260,442 shares of the company’s stock, valued at $60,050,111.94. This trade represents a 0.12% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.30% of the stock is owned by company insiders.

CME Group Price Performance

Shares of CME stock opened at $269.80 on Monday. CME Group Inc. has a 52 week low of $218.31 and a 52 week high of $329.16. The stock has a market capitalization of $97.01 billion, a PE ratio of 22.88, a PEG ratio of 3.14 and a beta of 0.23. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02. The stock’s fifty day moving average is $250.20 and its 200-day moving average is $280.19.

CME Group (NASDAQ:CME) last released its quarterly earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.91 by $0.08. The business had revenue of $1.71 billion during the quarter, compared to analysts’ expectations of $1.68 billion. CME Group had a return on equity of 15.60% and a net margin of 63.30%.The firm’s revenue for the quarter was up .8% compared to the same quarter last year. During the same period in the previous year, the business posted $2.96 earnings per share. Equities research analysts expect that CME Group Inc. will post 12.27 EPS for the current fiscal year.

CME Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, September 25th. Stockholders of record on Wednesday, September 9th will be given a dividend of $1.30 per share. This represents a $5.20 dividend on an annualized basis and a dividend yield of 1.9%. The ex-dividend date is Wednesday, September 9th. CME Group’s dividend payout ratio is presently 44.11%.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on CME. Piper Sandler lowered their target price on shares of CME Group from $329.00 to $295.00 and set an “overweight” rating on the stock in a report on Wednesday, July 15th. Erste Group Bank lowered shares of CME Group from a “buy” rating to a “hold” rating in a research report on Friday, June 5th. JPMorgan Chase & Co. boosted their price target on shares of CME Group from $249.00 to $250.00 and gave the company an “underweight” rating in a research report on Thursday, July 23rd. Morgan Stanley upped their price objective on shares of CME Group from $324.00 to $330.00 and gave the stock an “overweight” rating in a research note on Thursday, July 23rd. Finally, Raymond James Financial reaffirmed an “outperform” rating and set a $320.00 price objective on shares of CME Group in a report on Thursday, July 2nd. Ten analysts have rated the stock with a Buy rating, five have issued a Hold rating and three have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, CME Group presently has a consensus rating of “Hold” and an average target price of $291.81.

About CME Group

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.